Clinical Trial Update: Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing escitalopram for major depressive disorder in patients with temporal lobe epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Temporal Lobe Epilepsy

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Conrad, Erich J., M.D. | Conditions: Major Depression, Temporal Lobe Epilepsy | Phase 4 | Status: COMPLETED